We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Orlistat

Orlistat is a medication used to manage obesity. It works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. By inhibiting this enzyme, Orlistat reduces the absorption of dietary fat.Here are some key medical uses of Orlistat: Weight Loss,Improvement in Insulin Sensitivity

Synchemia specializes in supply of Orlistat impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Orlistat is a medication used to treat obesity and ensuring the purity and quality of its impurities is crucial for pharmaceutical manufacturing and regulatory compliance. If you have any specific questions about Orlistat impurities or related topics, feel free to ask!

download image Download catalogue

Pharmaceutical Reference Standards

Orlistat USP Related Compound E
Orlistat USP Related Compound E
CAT No SRC-O15047
CAS No 1072902-75-0
Mol.F. C29H53NO5
Mol.Wt. 495.7 g/mol
INV STATUS UNDER SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.